Age-specific incidence rates of other common cancers in Gambian Males and Females, 1990-2009.

<p>Age-specific incidence rates of other common cancers in Gambian Males and Females, 1990-2009.</p

Age-specific incidence rates of liver cancer by period in female Gambians.

<p>Age-specific incidence rates of liver cancer by period in female Gambians.</p

Estimated population at risk by age group and sex: The Gambia, 1990-2009.

<p>Estimated population at risk by age group and sex: The Gambia, 1990-2009.</p

Age-specific incidence rates of cervix cancer by period.

<p>Age-specific incidence rates of cervix cancer by period.</p

Microsatellite tracking assay linking DNA from patient peripheral blood mononuclear cells (PBMC), tumor surgical specimen (Surg

<p><b>Copyright information:</b></p><p>Taken from "Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)"</p><p>http://www.biomedcentral.com/1471-2407/7/225</p><p>BMC Cancer 2007;7():225-225.</p><p>Published online 18 Dec 2007</p><p>PMCID:PMC2241840.</p><p></p> Spec.) and xenograft to the Capi3 cell line

24 colour multifish karyotype showing the complexity of the genomic rearrangements with rearranged chromosomes in most pairs and several unidentified marker chromosomes (bottom left)

<p><b>Copyright information:</b></p><p>Taken from "Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)"</p><p>http://www.biomedcentral.com/1471-2407/7/225</p><p>BMC Cancer 2007;7():225-225.</p><p>Published online 18 Dec 2007</p><p>PMCID:PMC2241840.</p><p></p> Of particular interest are the translocation of chromosome 21 (in green) to the distal chromosome 4 (in grey) and the loss of chromosomes 9. In this cell, there were 2 der(3)t(3, 15) instead of one in most other cells which were analyzed

OR (95% CI) of breast cancer in pre-menopausal women according to the use of hormonal contraceptive treatment.

<p>(*) Adjusted for: age, socioeconomically status (high/medium/low), BMI (kg/m2), familial history of breast cancer in first degree relatives (yes/no), diabetes(yes/no), number of full term pregnancy, age at first full term pregnancy (years), total duration of breast feeding (months) and age at menarche (years).</p><p>(**) additional adjusted for European ancestry.</p><p>(***) We defined the recent use as the reported use of contraceptive treatment during the year prior to the date of interview.</p

Gene expression for all probes and for restricted sets of probes.

<p>Over-all rate of expression changes for all probes in all samples combined, in LC and HCC samples and in peripheral and central samples are estimated as percent-change per hour. Expression levels changes are also estimated for different sets of probes (lowest and highest 5% of geometric mean expression, probes in warm ischemia genes and probes in HCC genes).</p

OR (95% CI) of breast cancer in post-menopause women according to the use of hormone replacement therapy.

<p>(*) Adjusted for: age, socioeconomic status (high/medium/low), BMI (kg/m2), familial history of breast cancer in first degree relatives (yes/no), diabetes(yes/no), number of full term pregnancy, age at first full term pregnancy (years), total duration of breast feeding (months) and age at menarche (years).</p><p>(**) additional adjusted for European ancestry.</p><p>(***) We defined the recent use as the reported use of menopausal hormone therapy during the year prior to the date of interview.</p

Hierarchical cluster analysis of all samples following log-transformation and quantile normalization of the microarray data.

<p>Dendrogram for clustering experiments was created using centred correlation and average linkage method. Length of nodes corresponds to correlation between samples. HCC4_5P: HCC from patient 4 taken at the periphery of the tumor and maintained at room temperature and then frozen in liquid nitrogen at t5 (min).</p